Contact this trialFirst, we need to learn more about you.
Anti-diabetic agent
ORMD-0801 for Diabetes
Recruiting1 awardPhase 3
Dallas, Texas
This trial is testing the effectiveness and safety of a new oral capsule for patients with Type 2 Diabetes who haven't responded well to other medications. 300 patients will be enrolled in the study and will
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service